Alphabiome
Latest round
- Seed
Last raised
- May 2025
Total raised
- $8M
Investors
- 1
About Alphabiome
Alphabiome Ltd specializes in microbiome analytics aimed at improving drug development and patient outcomes. Founded in 2022, the company has conducted one deal to date. Dr. Yaniv Altshuler, CEO and Founder of Alphabiome Ltd Alphabiome specializes in AI-powered microbiome intelligence solutions aimed at enhancing precision medicine. The company’s core product offerings center around its proprietary technology that analyzes microbial DNA to extract genetic biomarkers, enabling it to predict the efficacy of various biological and biochemical treatments. This technology identifies over 100,000 biomarkers, facilitating optimized drug development and personalized treatment selection. Alphabiome's solutions are primarily targeted at pharmaceutical companies and healthcare providers seeking to enhance drug efficacy and patient outcomes.Alphabiome generates revenue through partnerships and collaborations with pharmaceutical companies, leveraging its microbiome insights to improve drug response predictions. The business model encompasses B2B transactions, where clients access the proprietary platform for drug development and personalized medicine solutions. Clients engage in structured agreements that may involve licensing fees or revenue-sharing arrangements based on the efficacy of the treatments developed using Alphabiome's technology.00 mn to expand R&D, highlight its commitment to scaling operations and further developing its innovative solutions. to enhance its microbiome analytics platform and support the development of new precision health solutions. The company aims to expand its presence in North America and Europe and will strategically seek to enter additional markets by the end of 2026.
Who invested in Alphabiome
1 investor across 1 round
See all investors in Alphabiome
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 6, 2025
Amount
$8M
Investors
Questions about Alphabiome
Who invested in Alphabiome?
Alphabiome has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alphabiome raised?
Alphabiome has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Alphabiome last raise money?
Alphabiome's most recent round on record is a Seed, in May 2025.
What does Alphabiome do?
Alphabiome Ltd specializes in microbiome analytics aimed at improving drug development and patient outcomes.
Where is Alphabiome headquartered?
Alphabiome is headquartered in Israel.
Which VCs invest in companies like Alphabiome?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Alphabiome's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Alphabiome? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.